MétaCan
Menu
Retour à la cohorte
Enregistrement W4411747446 · doi:10.1093/humrep/deaf097.695

P-389 Ovarian stimulation for fertility preservation in adolescents and young women with cancer

2025· article· en· W4411747446 sur OpenAlexaff
Y Perra, Florence Dumas, Belina Carranza‐Mamane, D. Delrieu, J Minano Masip, É. Monceau, Camille Sylvestre, Paul Desrosiers, Laurence Bissonnette, Elias M. Dahdouh

Notice bibliographique

RevueHuman Reproduction · 2025
Typearticle
Langueen
DomaineMedicine
ThématiqueReproductive Biology and Fertility
Établissements canadiensCentre Hospitalier Universitaire Sainte-JustineUniversité de Montréal
Organismes subventionnairesnon disponible
Mots-clésFertility preservationFertilityStimulationGynecologyMedicineCancerOncologyInternal medicineEnvironmental healthPopulation

Résumé

récupéré en direct d'OpenAlex

Abstract Study question Is controlled ovarian stimulation (COS) for fertility preservation (FP) for oncologic reasons different in adolescents when compared to young women of reproductive age? Summary answer Adolescents produce more mature oocytes (metaphase II) than women 18-25 and 26-35, require lower FSH doses than women aged 26–35, with similar stimulation durations. What is known already Each year, thousands of children and adolescents around the world develop cancer, with leukemia, brain tumors, lymphomas, and solid tumors (e.g. neuroblastomas) being most common. Advances in cancer treatments have increased 10-year survival rates. However, cancer treatments can impair ovarian function, causing infertility and even premature ovarian insufficiency. It is imperative to offer FP to pediatric cancer patients, such as oocyte or ovarian tissue cryopreservation. Random-start ovarian stimulation protocols help minimize oncologic treatment delays. Pediatric cancer patients may require adjusted protocols due to altered gonadotropin responses and hypothalamic-pituitary immaturity. Data on efficacy, feasibility and complications in adolescent FP remains limited. Study design, size, duration This retrospective cohort study compares adolescents (menarche–17 years) to women aged 18-25 and 26-35 undergoing FP before cancer treatments, from 2013 to 2022, in the same assisted reproduction technology center. The study includes 42 teenagers and 132 young women, with data obtained from archived digital medical records. The primary outcome was the number of mature oocytes retrieved after COS. Secondary outcomes included: total retrieved oocyte count, FSH dose, stimulation duration, follicle count, and complications. Participants/materials, setting, methods Participants must have undergone COS for FP due to oncological reasons. Exclusion criteria include patients with advanced reproductive age (>35 years) and those undergoing social elective FP or COS for infertility. The study analyzed dependent variables (mature metaphase II oocytes retrieved) and independent variables (age, AMH, BMI, prior treatments, fertility treatment timing, stimulation phase, FSH dose, stimulation duration, complications, cryopreservation method, reimplantation timing). Confounding factors included demographics, ovarian reserve, PCOS, obstetric history, and oncological treatment. Main results and the role of chance 42 adolescents (menarche-17), 42 women aged 18-25, and 90 women aged 26-35 met our inclusion criteria. The most common oncological diagnosis in adolescents and women <25 years of age was lymphoma (52%), while breast cancer was the most prevalent among women >25 years (72%). GnRH antagonist stimulation protocols were used across all groups. On average, the total number of oocytes retrieved per individual was 19, 16, and 13 for the three age groups, respectively (p = 0.003). The number of mature oocytes retrieved was 13, 12, and 9, respectively (p = 0.003). The FSH dose required for stimulation was 2795, 2672, and 3355 IU per group (p = 0.086). There were no significant differences in the duration of stimulation or in the number of follicles on ultrasound. Complications associated with ovarian stimulation were rare across all groups. However, moderate ovarian hyperstimulation syndrome occurred more frequently in adolescents (12%) compared to those aged 26-35 years (2%). COS resulted in a higher number of mature in adolescents compared to young women. Adolescents required a lower FSH dose than women aged 26-35. There were no differences in stimulation days or follicle count between groups. Ovarian hyperstimulation syndrome was more common in adolescents than in adults. Limitations, reasons for caution This is a retrospective investigation, thus prone to missing data and selection bias. More well-designed prospective trials are urgently warranted to clarify further the role of COS for oocytes freezing in adolescents with cancers. Wider implications of the findings This is one of the largest studies on COS in adolescents undergoing FP and confirms its feasibility and short-term safety. However, longer follow-up is warranted; reproductive outcomes of vitrified oocytes from adolescents are needed to confirm the efficacy and safety of FP in this population. Trial registration number No

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,001
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,029
Score d'incertitude au seuil0,323

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0010,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0000,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,035
Tête enseignante GPT0,327
Écart entre enseignants0,292 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueHuman ReproductionMême sujetReproductive Biology and FertilityTravaux en français237 207